Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Global Self-Injections Market Trends, 2017-2024

"Global Self-Injections Market – Trends and Forecast to 2024"
Data Bridge Market Research | 23.11.2017

The latest ready report titled “Global Self-Injections Market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024”, also the Global Self-Injections Market, By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel, Geography (North America, Europe, APAC, MEA, South America) – Trends and Forecast to 2024

This report consists of below pages:


  • No of pages: 350

  • No of Figures: 60

  • No of Tables: 220


Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-self-injections-market

The global self-injections market is expected to grow exponentially in the forecast period. The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases, chronic diseases include heart disease, diabetes, stroke, and chronic respiratory problems.

Competitive Landscape:

The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major Companies operating in this market are:

  • Abbvie, Inc.

  • Antares Pharma

  • 3M

  • Becton Dickinson & Company

  • Baxter International Inc.

  • Penjet Corporation

  • PharmaJet

  • GerresheimerAG

  • Pfizer Inc.

  • Terumo Corporation

  • Mylan N.V.

  • SHL Group

  • Bespak

  • Janssen Biotech Inc.

  • Insulet Corporation

  • Unilife Corporation

  • West Pharmaceutical Services, Inc.

  • Ypsomed

  • Eli lilly and Company

  • Haselmeier AG

  • Alkermes

  • AptarPharma

  • Credence MedSystems, Inc.

  • SchottAG

  • Owen Mumford Ltd.

  • Glide Technologies


View Full Report @ http://databridgemarketresearch.com/reports/global-self-injections-market-/

Report Segmentation:

The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography.

On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.

The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.

The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into automated and manual. The design segment is further categorized into standardized and customized. The usability segment is further categorized into reusable and disposable.

The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized.

The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The conventional drug delivery segment is categorized into solutions, reconstituted/lyophilized formulations, suspensions and emulsions. The novel drug delivery formulations market is segmented into colloidal dispersions, and microparticles.

Based on therapeutic application, the global self-injections market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.

On the basis of route of administration, the global self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.

On the basis of end-user, the global self-injections market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.

Based on geography the global self-injections market is segmented into:

  • North America

  • Europe

  • Asia-Pacific

  • South America

  • Middle East and Africa

  • Rest of the World


For More Details In-Depth Enquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-self-injections-market

TABLE OF CONTENTS:

  1. INTRODUCTION

  2. MARKET SEGMENTATION

  3. MARKET OVERVIEW


3.1. DRIVERS

3.2. RESTRAINTS

3.3. OPPORTUNITY

3.4. CHALLENGES

  1. EXECUTIVE SUMMARY

  2. PREMIUM INSIGHTS

  3. GLOBAL SELF-INJECTION MARKET, REGULATORY


6.1. OVERVIEW

6.2. U.S. FDA APPROVAL

6.3. CE MARKING (EUROPEAN CONFORMITY)

  1. GLOBAL SELF-INJECTION MARKET, REIMBUSEMENT


7.1. OVERVIEW

7.2. REIMBURSEMENT SCENARIO

  1. GLOBAL SELF-INJECTION MARKET, BY TYPE


8.1. OVERVIEW

8.2. GLOBAL SELF-INJECTION MARKET, BY PRODUCT TYPE

  1. GLOBAL SELF-INJECTION MARKET, BY APPLICATION


9.1. OVERVIEW

9.2. GLOBAL SELF-INJECTION MARKET, BY APPLICATION

9.3. HORMONAL DISORDERS

9.4. ONCOLOGY

9.5. AUTOIMMUNE DISEASES

9.6. ORPHAN DISEASE

9.7. OTHER APPLICATIONS

  1. GLOBAL SELF-INJECTION MARKET, BY USAGE PATTERN


10.1. OVERVIEW

10.2. CURATIVE CARE

10.3. IMMUNIZATIONS

10.4. OTHER USAGE PATTERN

  1. GLOBAL SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION


11.1. OVERVIEW

11.2. SKIN

11.3. CIRCULATORY/ MUSKOSKELETAL

11.4. ORGANS

11.5. CENTRAL NERVOUS SYSTEM

  1. GLOBAL SELF-INJECTION MARKET, BY END USER


12.1. OVERVIEW

12.2. HOSPITALS AND CLINICS

12.3. HOME HEALTHCARE SETTINGS

12.4. RESEARCH LABORATORIES

12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES

12.6. OTHER END USER

  1. GLOBAL SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL


13.1. OVERVIEW

13.1.1. HOSPITAL PHARMACY

13.1.2. PHARMACY STORES

13.1.3. DIRECT TENDER

13.1.4. ONLINE PHARMACY

  1. GLOBAL SELF-INJECTION MARKET, BY GEOGRAPHY


14.1. OVERVIEW

14.2. NORTH AMERICA

14.2.1. U.S.

14.2.2. CANADA

14.2.3. MEXICO

14.3. EUROPE

14.3.1. GERMANY

14.3.2. FRANCE

14.3.3. UK

14.3.4. SWITZERLAND

14.3.5. SPAIN

14.3.6. ITALY

14.3.7. NETHERLANDS

14.3.8. RUSSIA

14.3.9. TURKEY

14.3.10. BELGIUM

14.3.11. REST OF EUROPE

14.4. APAC

14.4.1. JAPAN

14.4.2. CHINA

14.4.3. SOUTH KOREA

14.4.4. INDIA

14.4.5. AUSTRALIA

14.4.6. SINGAPORE

14.4.7. THAILAND

14.4.8. MALAYSIA

14.4.9. INDONESIA

14.4.10. PHILIPPINES

14.4.11. REST OF APAC

14.5. SOUTH AMERICA

14.5.1. BRAZIL

14.5.2. REST OF SOUTH AMERICA

14.6. MEA

14.6.1. SOUTH AFRICA

14.6.2. REST OF MEA

  1. GLOBAL SELF INJECTION MARKET, COMPANY LANDSCAPE


15.1. COMPANY SHARE ANALYSIS: GLOBAL

15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

15.3. COMPANY SHARE ANALYSIS: EUROPE

15.4. COMPANY SHARE ANALYSIS: APAC

  1. COMPANY PROFILES


16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)

16.3. SANOFI

16.4. SANDOZ INTERNATIONAL GMBH

16.6. UNILIFE CORPORATION

16.7. WEST PHARMACEUTICAL SERVICES, INC

16.8. PFIZER INC.

16.9. IMPAX LABORATORIES, INC.

16.10. PENJET CORPORATION

16.12. WILHELM HASELMEIER GMBH & CO. KG

16.13. ANTARES PHARMA

16.15. GERRESHEIMER AG

16.16. MYLAN N.V

16.17. NOVO NORDISK

16.18. OWEN MUMFORD LTD

16.19. PHARMAJET

16.20. SHL GROUP

16.21. YPSOMED

  1. RELATED REPORTS


Related Report

Global Human Insulin Drugs and Delivery Devices Market – Industry Trends and Forecast to 2024

Global Human Insulin Drugs and Delivery Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-human-insulin-drugs-and-delivery-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Img of Data Bridge Market Research
About the tenderer: Data Bridge Market Research

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm.